qRT-PCR results showed that the expression of MAP7D3 was upregulated in 63.8% of LN metastatic tumors (23/36) when compared with the matched primary tumors (Fig. 5B), indicating that MAP7D3 plays an essential role in TNBC metastatic progression. The gene discussed is MAP7D3; the disease is metastatic neoplasm.